Regulatory B10 Cells Increase after Rituximab Therapy but Not after Conventional Immunosuppression in Patients with Pemphigus.
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Author
Chen, AlanYoshizaki, Ayumi
Miyagaki, Tomomitsu
Streilein, Robert D
Tedder, Thomas F
Hall, Russell P
Date
2021-02Journal
Journal of Investigative DermatologyPublisher
Elsevier B. V.Type
Article
Metadata
Show full item recordIdentifier to cite or link to this item
http://hdl.handle.net/10713/14733ae974a485f413a2113503eed53cd6c53
10.1016/j.jid.2020.06.018
Scopus Count
Collections
Related articles
- Low-dose rituximab and concurrent adjuvant therapy for pemphigus: Protocol and single-centre long-term review of nine patients.
- Authors: Robinson AJ, Vu M, Unglik GA, Varigos GA, Scardamaglia L
- Issue date: 2018 Feb
- Role of B cells in immune-mediated dermatoses.
- Authors: Wang WM, Guo L, Jin HZ
- Issue date: 2020 Oct
- Decreased level of interleukin-10-producing B cells in patients with pemphigus but not in patients with pemphigoid.
- Authors: Kabuto M, Fujimoto N, Takahashi T, Tanaka T
- Issue date: 2017 May
- [Effectiveness and safety of rituximab in pemphigus vulgaris].
- Authors: Alonso Sánchez A, García Rodríguez S, López Avila A, Rabell Iñigo S
- Issue date: 2010 Mar-Apr
- [Therapy of pemphigus].
- Authors: van Beek N, Zillikens D, Schmidt E
- Issue date: 2019 Apr